Krop IE, Masuda N, Mukohara T, Takahashi S, et al. Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II J Clin Oncol 2023 Oct 6:JCO2300882. doi: 10.1200/JCO.23.00882.
PMID: 37801674